Literature DB >> 32207539

Skin Infections Caused by Staphylococcus aureus.

Pascal Del Giudice1.   

Abstract

Staphylococcus aureus is the most common pathogen involved in skin infections worldwide, regardless of the patient's age, the climate or geographical area. The main skin clinical manifestations can be linked to a few toxins produced by the bacteria, which give rise to a rich and varied clinical spectrum. Panton Valentine leucocidin, exfoliatins, enterotoxins and toxin shock syndrome toxin 1 are the main toxins involved in most dermatological manifestations associated with S. aureus. Other less frequent cutaneous manifestations can occur in endocarditis, bacteraemia. Currently, the most important event is worldwide emergence of community-acquired S. aureus resistant to methicillin (CA-MRSA), mainly causing skin infections.

Entities:  

Keywords:  abscess; bacterial skin infections; cellulitis; furuncle; staphylococcus aureus; skin infections

Mesh:

Substances:

Year:  2020        PMID: 32207539      PMCID: PMC9128951          DOI: 10.2340/00015555-3466

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  76 in total

1.  Dissemination of multiple MRSA clones among community-associated methicillin-resistant Staphylococcus aureus infections from Japanese children with impetigo.

Authors:  Ken Hisata; Teruyo Ito; Nobuaki Matsunaga; Mitsutaka Komatsu; Jingxun Jin; Shanshuang Li; Shinya Watanabe; Toshiaki Shimizu; Keiichi Hiramatsu
Journal:  J Infect Chemother       Date:  2011-02-17       Impact factor: 2.211

Review 2.  Recurrent furunculosis: a review of the literature.

Authors:  M Demos; M P McLeod; K Nouri
Journal:  Br J Dermatol       Date:  2012-10       Impact factor: 9.302

Review 3.  Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

Authors:  S Ladhani; C L Joannou; D P Lochrie; R W Evans; S M Poston
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan.

Authors:  Takayuki Yamaguchi; Yoshiko Yokota; Jun Terajima; Tetsuya Hayashi; Martin Aepfelbacher; Masaru Ohara; Hitoshi Komatsuzawa; Haruo Watanabe; Motoyuki Sugai
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

5.  A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.

Authors:  Robert S Daum; Loren G Miller; Lilly Immergluck; Stephanie Fritz; C Buddy Creech; David Young; Neha Kumar; Michele Downing; Stephanie Pettibone; Rebecca Hoagland; Samantha J Eells; Mary G Boyle; Trisha Chan Parker; Henry F Chambers
Journal:  N Engl J Med       Date:  2017-06-29       Impact factor: 91.245

6.  Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections.

Authors:  P Del Giudice; V Blanc; F Durupt; M Bes; J-P Martinez; E Counillon; G Lina; F Vandenesch; J Etienne
Journal:  Br J Dermatol       Date:  2006-01       Impact factor: 9.302

7.  Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome.

Authors:  Yasushi Hanakawa; Norman M Schechter; Chenyan Lin; Luis Garza; Hong Li; Takayuki Yamaguchi; Yasuyuki Fudaba; Koji Nishifuji; Motoyuki Sugai; Masayuki Amagai; John R Stanley
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  Enterotoxin B is the predominant toxin involved in staphylococcal scarlet fever in Taiwan.

Authors:  Chih-Chien Wang; Wen-Tsung Lo; Chen-Fang Hsu; Mong-Ling Chu
Journal:  Clin Infect Dis       Date:  2004-04-29       Impact factor: 9.079

9.  Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.

Authors:  A J O'Neill; A R Larsen; R Skov; A S Henriksen; I Chopra
Journal:  J Clin Microbiol       Date:  2007-03-07       Impact factor: 5.948

Review 10.  The public health control of scabies: priorities for research and action.

Authors:  Daniel Engelman; Paul T Cantey; Michael Marks; Anthony W Solomon; Aileen Y Chang; Olivier Chosidow; Wendemagegn Enbiale; Dirk Engels; Roderick J Hay; David Hendrickx; Peter J Hotez; John M Kaldor; Mike Kama; Charles D Mackenzie; James S McCarthy; Diana L Martin; Birhan Mengistu; Toby Maurer; Nebiyu Negussu; Lucia Romani; Oliver Sokana; Margot J Whitfeld; L Claire Fuller; Andrew C Steer
Journal:  Lancet       Date:  2019-06-06       Impact factor: 79.321

View more
  4 in total

1.  Antibacterial pathway of cefquinome against Staphylococcus aureus based on label-free quantitative proteomics analysis.

Authors:  Linglin Gao; Hao Zhu; Yun Chen; Yuhui Yang
Journal:  J Microbiol       Date:  2021-11-09       Impact factor: 3.422

2.  Novel Retro-Inverso Peptide Antibiotic Efficiently Released by a Responsive Hydrogel-Based System.

Authors:  Angela Cesaro; Rosa Gaglione; Marco Chino; Maria De Luca; Rocco Di Girolamo; Angelina Lombardi; Rosanna Filosa; Angela Arciello
Journal:  Biomedicines       Date:  2022-06-02

Review 3.  The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin.

Authors:  Yin-Ku Lin; Shih-Chun Yang; Ching-Yun Hsu; Jui-Tai Sung; Jia-You Fang
Journal:  Molecules       Date:  2021-10-22       Impact factor: 4.411

4.  Three-Dimensional Structure Characterization and Inhibition Study of Exfoliative Toxin D From Staphylococcus aureus.

Authors:  Anwar Ullah; Ajmal Khan; Ahmed Al-Harrasi; Kifayat Ullah; Asghar Shabbir
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.